Wealthcare Advisory Partners LLC Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)

Wealthcare Advisory Partners LLC reduced its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 0.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,876 shares of the company’s stock after selling 149 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Procter & Gamble were worth $4,085,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. MeadowBrook Investment Advisors LLC bought a new position in Procter & Gamble during the 4th quarter worth approximately $33,000. AllGen Financial Advisors Inc. raised its holdings in shares of Procter & Gamble by 0.3% during the fourth quarter. AllGen Financial Advisors Inc. now owns 20,679 shares of the company’s stock worth $3,030,000 after purchasing an additional 68 shares during the period. Metis Global Partners LLC boosted its holdings in shares of Procter & Gamble by 15.7% in the 4th quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after buying an additional 15,599 shares during the period. TCI Wealth Advisors Inc. lifted its holdings in Procter & Gamble by 16.6% in the fourth quarter. TCI Wealth Advisors Inc. now owns 15,164 shares of the company’s stock worth $2,222,000 after acquiring an additional 2,157 shares during the last quarter. Finally, W.H. Cornerstone Investments Inc. boosted its stake in Procter & Gamble by 14.4% in the fourth quarter. W.H. Cornerstone Investments Inc. now owns 8,511 shares of the company’s stock valued at $1,247,000 after acquiring an additional 1,074 shares during the period. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on PG. Barclays upped their price target on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. Raymond James raised their price objective on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. The Goldman Sachs Group began coverage on Procter & Gamble in a report on Friday, March 1st. They set a “neutral” rating and a $168.00 target price on the stock. Wells Fargo & Company increased their price target on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Finally, Argus upped their price objective on shares of Procter & Gamble from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $169.76.

Procter & Gamble Price Performance

Shares of PG stock traded down $0.02 during trading hours on Monday, reaching $164.44. 5,470,365 shares of the company were exchanged, compared to its average volume of 6,902,192. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $164.98. The stock’s fifty day moving average is $160.10 and its two-hundred day moving average is $154.37. The company has a market cap of $388.10 billion, a price-to-earnings ratio of 26.87, a P/E/G ratio of 3.34 and a beta of 0.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same period in the prior year, the business posted $1.37 earnings per share. Procter & Gamble’s revenue was up .6% compared to the same quarter last year. Sell-side analysts forecast that The Procter & Gamble Company will post 6.55 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.45%. The ex-dividend date is Thursday, April 18th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total value of $620,719.00. Following the completion of the sale, the insider now owns 11,886 shares of the company’s stock, valued at $1,908,891.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now owns 4,859 shares of the company’s stock, valued at $768,256.49. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 3,865 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the transaction, the insider now directly owns 11,886 shares of the company’s stock, valued at approximately $1,908,891.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 86,865 shares of company stock valued at $14,059,180. Corporate insiders own 0.17% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.